These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21397884)

  • 1. Determinants of medication incident reporting, recovery, and learning in community pharmacies: a conceptual model.
    Boyle TA; Mahaffey T; Mackinnon NJ; Deal H; Hallstrom LK; Morgan H
    Res Social Adm Pharm; 2011 Mar; 7(1):93-107. PubMed ID: 21397884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of process characteristics on quality-related event reporting in community pharmacy.
    Boyle TA; Scobie AC; MacKinnon NJ; Mahaffey T
    Res Social Adm Pharm; 2012; 8(1):76-86. PubMed ID: 22169174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of Quality-Related Event Standards of Practice by Community Pharmacies.
    Boyle TA; Bishop AC; Overmars C; MacMaster K; Mahaffey T; Zwicker B; MacKinnon NJ
    J Pharm Pract; 2015 Oct; 28(5):442-9. PubMed ID: 24532822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacy incident reporting: a new tool for community pharmacies in Canada.
    Ho C; Hung P; Lee G; Kadija M
    Healthc Q; 2010; 13 Spec No():16-24. PubMed ID: 20959726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting.
    Christensen ST; Søndergaard B; Honoré PH; Bjerrum OJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):399-404. PubMed ID: 21442686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety implications of standardized continuous quality improvement programs in community pharmacy.
    Boyle TA; Ho C; Mackinnon NJ; Mahaffey T; Taylor JM
    J Pharm Pract; 2013 Jun; 26(3):228-36. PubMed ID: 22842505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication safety in hospitals.
    Kirke C;
    Ir Med J; 2009; 102(10):339-41. PubMed ID: 20108808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for organizational change in patient safety initiatives.
    Anderson JG; Ramanujam R; Hensel D; Anderson MM; Sirio CA
    Int J Med Inform; 2006 Dec; 75(12):809-17. PubMed ID: 16870501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.
    Becker ML; Caspers PW; Kallewaard M; Bruinink RJ; Kylstra NB; Heisterkamp S; de Valk V; van der Veen AA; Stricker BH
    Pharm World Sci; 2007 Apr; 29(2):51-7. PubMed ID: 17187223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Likelihood of reporting adverse events in community pharmacy: an experimental study.
    Ashcroft DM; Morecroft C; Parker D; Noyce PR
    Qual Saf Health Care; 2006 Feb; 15(1):48-52. PubMed ID: 16456210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication errors involving oral chemotherapy.
    Weingart SN; Toro J; Spencer J; Duncombe D; Gross A; Bartel S; Miransky J; Partridge A; Shulman LN; Connor M
    Cancer; 2010 May; 116(10):2455-64. PubMed ID: 20225328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication incident recovery and prevention utilising an Australian community pharmacy incident reporting system: the QUMwatch study.
    Adie K; Fois RA; McLachlan AJ; Chen TF
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1381-1395. PubMed ID: 33646375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving medication administration error reporting systems. Why do errors occur?
    Wakefield BJ; Wakefield DS; Uden-Holman T
    Ambul Outreach; 2000; ():16-20. PubMed ID: 11067442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria.
    Oshikoya KA; Senbanjo IO; Njokanma OF
    Arch Dis Child; 2009 Jun; 94(6):469-73. PubMed ID: 19147621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing hospital culture and systems reduces drug errors and adverse events.
    Hume M
    Qual Lett Healthc Lead; 1999 Mar; 11(3):2-9. PubMed ID: 10351586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Student observations of medication error reporting practices in community pharmacy settings.
    Darbishire PL; Zhao JC; Sodhi A; Anderson CM
    Res Social Adm Pharm; 2019 Jul; 15(7):902-906. PubMed ID: 30852086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.